-
Start Preamble
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Noramco, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 12, 2022. Such persons may also file a written request for a hearing on the application on or before January 12, 2022.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on September 22, 2021, Noramco Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801-4417, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
Controlled substance Drug code Schedule Marihuana 7360 I Tetrahydrocannabinols 7370 I Nabilone 7379 II Phenylacetone 8501 II Opium, Raw 9600 II Poppy Straw Concentrate 9670 II Noroxymorphone 9668 II Tapentadol 9780 II The company plans to import Phenylacetone (8501), and Poppy Straw Concentrate (9670) to bulk manufacture other controlled substances for distribution to its customers. The company plans to import an intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol for distribution to its customers. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. No other activity for these drug codes is authorized for this registration.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.
Start SignatureBrian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-26906 Filed 12-10-21; 8:45 am]
BILLING CODE P
Document Information
- Published:
- 12/13/2021
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2021-26906
- Dates:
- Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 12, 2022. Such persons may also file a written request for a hearing on the application on or before January 12, 2022.
- Pages:
- 70866-70866 (1 pages)
- Docket Numbers:
- Docket No. DEA-927
- PDF File:
- 2021-26906.pdf